n
nDeverab offers a comprehensive treatment approach for GERD, acidity, and related gastric disorders, combining the potency of Rabeprazole (a superior PPI) with proven prokinetic agents for enhanced patient outcomes.
n

Available Combinations:

n

n
• Deverab-LS: Rabeprazole 20 mg + Levosulpiride SR 75 mg (Capsules)

n

• Deverab-DM: Rabeprazole 20 mg + Domperidone 10 mg (Tablets)

n

• Deverab-DSR: Rabeprazole 20 mg + Domperidone SR 30 mg (Capsules)

n

• Domperidone SR – Prevents nausea, vomiting, and bloating while improving gastric motility.

n

n

Why Deverab?

n

n
• Potency of Rabeprazole: Strong acid suppression with effective oesophagitis healing and long-term maintenance therapy.

n

• Enhanced Gastric Motility: Levosulpiride & Domperidone improve gastric emptying, relieve bloating, nausea, and dyspepsia.

n

• Clinically Proven Safety: Effective for both short-term relief and long-term therapy with better tolerability.

n

• Combination Synergy: Provides dual benefit—acid suppression plus symptom control (regurgitation, nausea, indigestion).

n

n

Therapeutic Benefits

n

n
• Deverab is effective in the management of: GERD associated with stress, Functional dyspepsia, Irritable bowel syndrome, Peptic oesophagitis, Peptic ulceration & related GI disorders, Reflux oesophagitis, Indigestion & bloating, Anxiety-related GI disorders, Essential cephalgia (GERD-linked headaches).

n

n

Why Deverab?

n

n
• Strong & sustained acid suppression

n

• Faster healing of oesophagitis & ulcers

n

• Relieves nausea, bloating & upper GI symptoms

n

• Effective in both acute & maintenance therapy

n

• Superior patient compliance with multiple dosage options

n

n